Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04053543 · ClinicalTrials.gov registry record · Phase 2
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
A Phase 2 study, sponsored by Complexa.
- Terminated
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT04053543 is a Phase 2 study that was terminated before completion, run by Complexa. The registered enrollment target is 33 participants.
The verdict
NCT04053543, a Phase 2 study, was terminated before completion, sponsored by Complexa.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
This is a Phase 2, multicenter, open-label extension (OLE) of study CXA-10-301, to evaluate the long term safety and efficacy of daily dosing of CXA-10.
Interventions
- DRUG CXA-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-08-09 |
| Est. Completion | 2020-08-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04053543
The ClinicalTrials.gov registry entry for NCT04053543 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Complexa, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CXA-10 is the first listed.
NCT04053543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04053543 about?
NCT04053543 is a clinical study titled "CXA-10 Study in Subjects With Pulmonary Arterial Hypertension". This is a Phase 2, multicenter, open-label extension (OLE) of study CXA-10-301, to evaluate the long term safety and efficacy of daily dosing of CXA-10.
What is the current status of trial NCT04053543?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2019-08-09. Estimated completion is 2020-08-12.
What interventions are being tested in trial NCT04053543?
The interventions under investigation include: CXA-10 (DRUG).
Who is sponsoring clinical trial NCT04053543?
This trial is sponsored by Complexa, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.